U.S. lawmakers call for morning-after pill approval (Reuter


Reuters - A bipartisan group of 62 U.S.
lawmakers have called on the new acting head of the Food and
Drug Administration to allow sales of Barr Pharmaceuticals
Inc's "morning-after" pill without a prescription, according to
a letter made public on Tuesday.